Photo from Emre Yekedüz/Twitter
Oct 25, 2023, 18:50
Emre Yekedüz: Our results including more than 20,000 patients were presented as a poster at ESMO23
Quoting Emre Yekedüz, Associate Professor of Medical Oncology at Ankara University, on X/Twitter:
”Our results including more than 20,000 patients were presented as a poster at ESMO23. Liver metastasis has the worst prognosis in patient with metastatic hormon-sensitive prostate cancer! Other visceral sites as not bad as liver. Does patients with visceral metastasis to only lung have a high risk disease? We clearly need a new prognostic score in prostate cancer. Many thanks for the outstanding mentoring by Toni Choueiri, Silke Gillessen, Yüksel Ürün and extremely huge contribution and effort by Renee Maria Saliby, Eddy Saad, Marc Eid, Karl Semaan! ”
Source: Emre Yekedüz/Twitter
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023